| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.17 | 0.03 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.12 | 0.03 |